Table 1.
Protein | CCaX | Prenylationc | Palmitoylation | Methylation | Reference(s) and source or accession no. |
---|---|---|---|---|---|
bCdc42 | CCIF | GG/Far | + | + | 21, this study |
Wrch-1 | CCFV | − | +d | 22 | |
RalA | CCIL | GG | + | + | 26, 29, this study |
RalB | CCLL | GG | + | 29, this study | |
PRL-1 | CCIQ | Far | 30 | ||
PRL-2 | CCVQ | Far | 30 | ||
PRL-3 | CCVM | Far | + | + | 30, this study |
PDE6α | CCIQ | Far | + | 41 | |
PDE6β | CCIL | GG | +e | 41 | |
PLA2γ | CCLA | Far | +f | 44 | |
SLFNL1 | CCVL | ? | ? | ? | NP_001161719 |
ASPA | CCLH | ? | ? | ? | NP_000040 |
MPI | CCLL | ? | ? | ? | NP_002426 |
The list of proteins was derived from known and hypothetical CaaX prenyltransferase substrates (60) and PRENbase (http://mendel.imp.ac.at/PrePS/PRENbase/).
Modifications identified in this study are in boldface type.
Far, farnesylation; GG, geranylgeranylation.
The second cysteine of the CCFV motif of Wrch-1 is palmitoylated.
Carboxymethylation of PDE6β is approximately 20 times lower than that of PDE6α.
The palmitoylation site(s) of PLA2γ was not identified.